文献速递肝胆胰外科

胰头和钩突部肿瘤机器人剜除术的短期和长期结局

Short-term and Long-term Outcomes of Robotic Enucleation of Tumors Located in the Pancreatic Head and Uncinate Process.
PubMed 文献 · Ann Surg · 2024-01-23

该回顾性分析纳入2005年1月至2021年12月因胰腺头颈部良性和低度恶性肿瘤接受机器人剜除术(REn)的患者,并与开放剜除术(OEn)组比较。REn在手术时间、出血量和临床相关术后胰瘘率方面优于OEn,胆漏、重大并发症、90天死亡率和住院时间两组相当,中位随访50个月时复发率及胰腺内外分泌功能两组相当。

要点

  • REn组中转开放率为零,手术时间90.0分钟 vs OEn组120.0分钟(P<0.001)。
  • REn组出血量20.0 mL vs OEn组100.0 mL(P=0.001)。
  • REn组临床相关术后胰瘘率43.5% vs OEn组61.1%(P=0.040)。

核心结论

  • 与OEn相比,REn治疗胰头和钩突部肿瘤改善了临床相关结局,未增加重大并发症,长期肿瘤学和功能结局相当。

研究设计与样本

  • 回顾性分析2005年1月至2021年12月所有因胰腺头颈部良性和低度恶性肿瘤接受REn的患者,并与相似的OEn组比较临床病理、围手术期和长期结局。
  • 共146例患者,其中92例接受REn,中转开放率为零。

主要发现

  • REn在手术时间(90.0分钟 vs 120.0分钟,P<0.001)、出血量(20.0 mL vs 100.0 mL,P=0.001)和临床相关术后胰瘘率(43.5% vs 61.1%,P=0.040)方面优于OEn。
  • 胆漏率、重大并发症、90天死亡率和住院时间两组相当。
  • REn后未发现C级术后胰瘘或IV/V级并发症。
  • 钩突部肿瘤和靠近主胰管的亚组分析未显示术后结局更差。
  • 中位随访50个月期间,REn在复发率和胰腺内分泌或外分泌功能方面与OEn相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess short-term and long-term outcomes following robotic enucleation (REn) of tumors in the proximal pancreas. BACKGROUND: Despite the advantages of preserving function via pancreatic enucleation, controversies persist, since this can be associated with severe complications, such as clinically relevant postoperative pancreatic fistula, especially when performed near the main pancreatic duct. The safety and efficacy of REn in this context remain largely unknown. METHODS: A retrospective analysis was performed of all patients who underwent REn for benign and low-grade malignant neoplasms in the pancreatic head and uncinate process between January 2005 and December 2021. Clinicopathologic, perioperative, and long-term outcomes were compared with a similar open enucleation (OEn) group. RESULTS: Of 146 patients, 92 underwent REn with a zero conversion-to-open rate. REn was superior to OEn in terms of shorter operative time (90.0 minutes vs 120.0 minutes, P< 0.001), decreased blood loss (20.0 mL vs 100.0 min, P =0.001), and lower clinically relevant postoperative pancreatic fistula rate (43.5% vs 61.1%, P =0.040). Bile leakage rate, major morbidity, 90-day mortality, and length of hospital stay were comparable between groups. No post-REn grade C POPF or grade IV/V complication was identified. Subgroup analyses for uncinate process tumors and proximity to the main pancreatic duct did not demonstrate inferior postoperative outcomes. In a median follow-up period of 50 months, REn outcomes were comparable to OEn regarding recurrence rate and pancreatic endocrine or exocrine function. CONCLUSIONS: REn for pancreatic head and uncinate process tumors improved clinically relevant outcomes without increased major complications compared to OEn, while demonstrating comparable long-term oncological and functional outcomes.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Ou H, Chen M, Qin K, et al. Short-term and Long-term Outcomes of Robotic Enucleation of Tumors Located in the Pancreatic Head and Uncinate Process. Ann Surg. 2024. PMID: 38258584. doi:10.1097/SLA.0000000000006198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。